drugset / Trial / NCT06151080
Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL
Phase 2
Recruiting
38 enrolled
The First Affiliated Hospital of Xiamen University
Fujian Cancer Hospital · collabJiangxi Provincial Cancer Hospital · collabSun Yat-sen University · collabThe First Affiliated Hospital with Nanjing Medical University · collab
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the efficacy and adverse effects of lenalidomide combined with G-CHOP(LO-CHOP) in the treatment of newly diagnosed diffuse large B-cell lymphoma with follicular lymphoma (CDLBCL-FL).
Timeline
- Start
- 2023-11-22
- Primary completion
- 2027-08-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lenalidomide | Other / unclassified | — | — |